Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Neuroscience Letters|September 12, 2013
Elevated levels of PPAR-gamma in the cerebrospinal fluid of patients with multiple sclerosisLevente Szalardy, Denes Zadori, Ervin Tanczos, et al.
Neuromolecular Medicine|January 1, 2005
Neuroprotective effects of phenylbutyrate against MPTP neurotoxicityGabriella Gardian, Lichuan Yang, Carine Cleren, et al.
Behavioural Brain Research|January 31, 2006
Behaviour changes in a transgenic model of Huntington's diseasePeter Klivenyi, Zsuzsanna Bende, Zsuzsanna Hartai, et al.
Journal of Neurochemistry|June 17, 2003
Increased survival and neuroprotective effects of BN82451 in a transgenic mouse model of Huntington's diseasePeter Klivenyi, Robert J Ferrante, Gabrielle Gardian, et al.
Behavioural Brain Research|July 19, 2016
Lack of age-related clinical progression in PGC-1α-deficient mice - implications for mitochondrial encephalopathiesLevente Szalardy, Mate Molnar, Rita Torok, et al.
Neuroscience Letters|July 25, 2013
Association of vitamin D receptor gene polymorphisms and Parkinson's disease in HungariansRita Török, Nora Török, Levente Szalardy, et al.
Brain Research|February 6, 2017
Effect of MPTP on mRNA expression of PGC-1α in mouse brainRita Torok, Andras Salamon, Evelin Sumegi, et al.
Neuro-Degenerative Diseases|February 15, 2013
Neuropathology of partial PGC-1α deficiency recapitulates features of mitochondrial encephalopathies but not of neurodegenerative diseasesLevente Szalardy, Denes Zadori, Imola Plangar, et al.
Pageof 6